Tricida, Inc. Insider Trading for April 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tricida, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Tricida, Inc. for April 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 7.49 | 523 | 3,917 | 23,556 | |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 2.39 | 523 | 1,250 | 17,275 | |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 1,744 | 2,930 | 5,818 | |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 210 | 353 | 630 | |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 1,250 | 2,100 | 7,562 | |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 523 | 16,726 | 255 | 778 to 255 (-67.22 %) |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 7.49 | 523 | 3,917 | 778 | 255 to 778 (+205.10 %) |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 523 | 16,726 | 255 | 778 to 255 (-67.22 %) |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 2.39 | 523 | 1,250 | 778 | 255 to 778 (+205.10 %) |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 1,744 | 55,773 | 255 | 2 K to 255 (-87.24 %) |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 1,744 | 2,930 | 1,999 | 255 to 2 K (+683.92 %) |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 210 | 6,716 | 255 | 465 to 255 (-45.16 %) |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 210 | 353 | 465 | 255 to 465 (+82.35 %) |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 29.98 | 1,250 | 37,475 | 255 | 1.5 K to 255 (-83.06 %) |
| Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 1,250 | 2,100 | 1,505 | 255 to 1.5 K (+490.20 %) |
| Apr 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.97 | 100 | 2,797 | 37,323 | 37.4 K to 37.3 K (-0.27 %) |
| Apr 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.46 | 3,900 | 107,094 | 37,423 | 41.3 K to 37.4 K (-9.44 %) |
| Apr 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.97 | 100 | 2,797 | 37,323 | 37.4 K to 37.3 K (-0.27 %) |
| Apr 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.46 | 3,900 | 107,094 | 37,423 | 41.3 K to 37.4 K (-9.44 %) |
| Apr 08 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 24.22 | 4,000 | 96,880 | 559,321 | 563.3 K to 559.3 K (-0.71 %) |